Sectoral Asset Management Inc Ultragenyx Pharmaceutical Inc. Transaction History

Sectoral Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$45.8 - $85.4 $196,940 - $367,220	4,300 New	4,300 $257,000
Q2 2021 Aug 16, 2021	SELL	$92.19 - $115.71 $10.3 Million - $13 Million	-112,200 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$106.9 - $167.73 $12 Million - $18.8 Million	112,200 New	112,200 $12.8 Million
Q3 2020 Nov 13, 2020	SELL	$72.98 - $90.0 $627,628 - $774,000	-8,600 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$46.91 - $78.22 $403,425 - $672,692	8,600 New	8,600 $673,000
Q1 2019 May 14, 2019	SELL	$39.87 - $69.36 $360,703 - $627,499	-9,047 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$71.81 - $90.15 $649,665 - $815,587	9,047 New	9,047 $691,000

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.14B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.